4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-001900
Senior VP, Chief Pharma Dev. sold 442 shares at $273.41 ($120,847)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2025-01-17 | Sale | −442 | $273.41 | $120,847 | 5,058 | D |
| Open-market sales · 442 sh · avg $273.41 · $120,847 | |||||||
Loading xslF345X05/wk-form4_1737158894.xml…